Recently, the FDA unveiled the Rare Disease Innovation Hub – a new model that aims to foster collaboration and advance outcomes for patients with rare diseases. We're grateful for the FDA’s commitment to this area and with our like-minded vision to improve the patient journey, we recognize the critical need to break down barriers and co-create solutions to increase equitable care for all patients – no matter who they are or where they live. Working to enhance patient outcomes is at the core of what we do and why we are committed to activating meaningful change and empowering innovation across the rare disease care paradigm. The establishment of the Innovation Hub signifies a step forward toward optimizing care for patients, and ultimately creating a brighter future for the rare disease community. Read the FDA’s full statement: https://lnkd.in/eT3ZEEge
Amazing strides
Devin Di Scala
3mo
Great news!
Healthcare
3mow